ASPRONI, Battistina
 Distribuzione geografica
Continente #
EU - Europa 50
NA - Nord America 11
AS - Asia 4
Totale 65
Nazione #
IT - Italia 46
US - Stati Uniti d'America 11
PK - Pakistan 3
GB - Regno Unito 2
CZ - Repubblica Ceca 1
DE - Germania 1
IN - India 1
Totale 65
Città #
Sassari 36
Tappahannock 6
Islamabad 3
Alghero 2
Haverhill 2
Alexandria 1
Council Bluffs 1
Ferrara di Monte Baldo 1
Fleming Island 1
Hyderabad 1
Maleo 1
Naples 1
Nuthetal 1
West Lafayette 1
Totale 58
Nome #
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2 receptor antagonists/inverse agonists, file e1dc1a2d-df73-1507-e053-3a05fe0ac7a3 16
Tricyclic Pyrazoles. Part 8. Synthesis, Biological Evaluation and Modelling of Tricyclic Pyrazole Carboxamides as Potential CB2 Receptor Ligands with Antagonist/Inverse Agonist Properties., file e1dc1a2d-cac9-1507-e053-3a05fe0ac7a3 7
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking, file e1dc1a2d-dca6-1507-e053-3a05fe0ac7a3 7
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2 receptor antagonists/inverse agonists, file e1dc1a2c-a2a4-1507-e053-3a05fe0ac7a3 4
Pyridinyl- and pyridazinyl-3,6-diazabicyclo[3.1.1]heptane-anilines: novel selective ligands with subnanomolar affinity for α4β2 nACh receptorS, file e1dc1a2d-d389-1507-e053-3a05fe0ac7a3 4
Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazoles: A versatile architecture for CB2 selective ligands, file e1dc1a2a-4073-1507-e053-3a05fe0ac7a3 3
Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles, file e1dc1a2c-1481-1507-e053-3a05fe0ac7a3 3
Nuovi derivati 1,2-difenil-imidazolici come potenti ed efficaci modulatori allosterici positivi del recettore GABAA, file e1dc1a2c-fdaa-1507-e053-3a05fe0ac7a3 3
Multitarget-directed tricyclic pyridazinones as G protein-coupled receptor ligands and cholinesterase inhibitors, file e1dc1a2a-3b77-1507-e053-3a05fe0ac7a3 2
Determination amphetamine-derived designer drugs in human urine by SPE extraction and capillary electrophoresis with mass spectrometry detection, file e1dc1a2a-3d0d-1507-e053-3a05fe0ac7a3 2
Determination of Amphetamines in human whole blood by capillary electrophoresis with photodiode array detection, file e1dc1a2a-3f93-1507-e053-3a05fe0ac7a3 2
The novel cannabinoid antagonist SM-11 reduces hedonic aspect of food intake through a dopamine-dependent mechanism, file e1dc1a2c-94a5-1507-e053-3a05fe0ac7a3 2
Thienocinnolinone alkanoic acid derivatives as aldose reductase inhibitors, file e1dc1a2a-3a61-1507-e053-3a05fe0ac7a3 1
Ethyl 2-(4-bromophenyl)-1-(2,4-dichlorophenyl)-1H-4-imidazolecarboxylate is a Novel Positive Modulator of GABAA Receptors, file e1dc1a2a-4a5a-1507-e053-3a05fe0ac7a3 1
Tricyclic pyrazoles. Part 5. novel 1,4-Dihydroindeno[1,2-c]pyrazole CB2 ligands using molecular hybridization based on scaffold hopping, file e1dc1a2a-6241-1507-e053-3a05fe0ac7a3 1
Synthesis and pharmacological evaluation of novel 4-Alkyl-5-thien-2'-yl pyrazole carboxamides, file e1dc1a2a-62d4-1507-e053-3a05fe0ac7a3 1
Synthesis of biologically active bridged diazabicycloheptanes, file e1dc1a2a-65ac-1507-e053-3a05fe0ac7a3 1
Development of oxygen-bridged pyrazole-based structures as cannabinoid receptor 1 ligands, file e1dc1a2b-febd-1507-e053-3a05fe0ac7a3 1
Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 Ligands, file e1dc1a2c-92e1-1507-e053-3a05fe0ac7a3 1
Novel pyrrolocycloalkylpyrazole analogues as CB1 ligands, file e1dc1a2c-a8a5-1507-e053-3a05fe0ac7a3 1
Tricyclic Pyrazole-Based Compounds as Useful Scaffolds for Cannabinoid CB1/CB2 Receptor Interaction, file e1dc1a2c-d6d8-1507-e053-3a05fe0ac7a3 1
Isolation, characterization and pharmacological activity ofMagydaris pastinacea(Lam.) Paol.glucosides, file e1dc1a2d-0b95-1507-e053-3a05fe0ac7a3 1
Totale 65
Categoria #
all - tutte 118
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0000 00 00 0010
2019/20201 1000 00 00 0000
2020/20214 0000 00 03 0010
2021/202222 0000 00 00 41134
2022/202323 1010 03 180 0000
Totale 65